Deep Learning the Crosstalk between Follicular Helper T cells and Type 1 Diabetes
DOI:
https://doi.org/10.54097/hset.v36i.5784Keywords:
Follicular Helper T Cells, Inflammation, Type 1 Diabetes.Abstract
Damaged beta cells can lead to type 1 diabetes (T1D), which influences people worldwide. Individuals with T1D have higher risk of developing other cardiovascular disease although life-insulin injection is taken. However, the specific reasons which trigger the destruction of beta cells are still not fully understood. Researchers demonstrated the importance of follicular helper T (Tfh) cells in T1D development. Tfh cells refer to a specific subpopulation of CD4+ T cells which normally express an upregulated C-X-C chemokine receptor type 5 (CXCR5). The dysregulated Tfh cells can be widely found in T1D individuals, which could be caused by excessive antigen presenting process. Mutation of several gene are also shown to be associated with the abnormal Tfh cells. Furthermore, increasing Tfh cells can secret more interleukin-21 (IL-21) to recruit CD8+ lymphocyte to damage beta cells. Besides, antibodies producing function of B cells could also be enhanced by Tfh cells to accelerate T1D. In this project, the mechanism of Tfh involving in T1D will be explained in detail.
Downloads
References
Gregory G A, Robinson T I G, Linklater S E, et al. Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study[J]. The Lancet Diabetes & Endocrinology, 2022.
Geravandi S, Liu H, Maedler K. Enteroviruses and T1D: is it the virus, the genes or both which cause T1D[J]. Microorganisms, 2020, 8(7): 1017.
Shahjalal H M, Abdal Dayem A, Lim K M, et al. Generation of pancreatic β cells for treatment of diabetes: advances and challenges[J]. Stem cell research & therapy, 2018, 9(1): 1-19.
Wong M S, Hawthorne W J, Manolios N. Gene therapy in diabetes[J]. Self/nonself, 2010, 1(3): 165-175.
Shao F, Zheng P, Yu D, et al. Follicular helper T cells in type 1 diabetes[J]. The FASEB Journal, 2020, 34(1): 30-40.
Washburn R L, Mueller K, Kaur G, et al. C-peptide as a therapy for type 1 diabetes mellitus[J]. Biomedicines, 2021, 9(3): 270.
Ueda H, Howson J M M, Esposito L, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease[J]. Nature, 2003, 423(6939): 506-511.
Sage P T, Paterson A M, Lovitch S B, et al. The coinhibitory receptor CTLA-4 controls B cell responses by modulating T follicular helper, T follicular regulatory, and T regulatory cells[J]. Immunity, 2014, 41(6): 1026-1039.
Sutherland A P R, Van Belle T, Wurster A L, et al. Interleukin-21 is required for the development of type 1 diabetes in NOD mice[J]. Diabetes, 2009, 58(5): 1144-1155.
Vandamme C, Kinnunen T. B cell helper T cells and type 1 diabetes[J]. Scandinavian Journal of Immunology, 2020, 92(4): e12943.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
